Skip to content

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again

      gettyimages-1436389224-170667a 1.png
      Center for U.S. Healthcare Policy Research
      by J&J Innovative Medicine
      Evidence for the future of health policy
      Our research initiatives and scientific collaborations enable evidence-based policy-making that support patient access, medical innovation and healthcare transparency.
      • Respect for individual patient needs should be at the heart of evaluating medical innovation. We study and develop patient-centered and clinically-driven approaches to value assessment.

        The objective: Ensure that methods and approaches reflect the holistic value to patients, as well as broader benefits to the healthcare system and society.
      • Patients in the U.S. benefit from the earliest access to the most advanced treatments. Our research examines the systems and policies that govern how patients obtain medicines and receive appropriate treatment.

        The objective: Enhance patient affordability and access to high-value therapies so that everyone can achieve their full potential and live healthier, more fulfilling lives.
      • The U.S. leads the world with the most robust medical research and development ecosystem, uniquely combining public and private-sector contributions. Our research examines policies that can support and strengthen this dynamic ecosystem.

        The objective: Demonstrate the importance of accelerating medical innovation to achieve greater advancements in human health.
      Recent content
      Read recent commentary and research. [NOTE: WE CAN SET THIS MANUALLY BASED ON IMPORTANCE, DOES NOT HAVE TO BE MOST RECENT]
      Since 2016, Johnson & Johnson Innovative Medicine has published our annual Transparency Report to provide visibility into our pricing, discounts and rebates.
      Policy perspectives